Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2003
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003039473A3 Method for treating or preventing inflammatory diseases
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002067688A8 Noninvasive measurements of chemical substances
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199551 Calcium blockers to treat proliferative vitreoretinopathy
10/23/2003US20030199546 6-(((2S)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199509 For treatment of glaucoma and/or ocular hypertension
10/23/2003US20030199507 Combination of brimonidine and timolol for topical ophthalmic use
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199491 Quinoline derivatives having vegf inhibiting activity
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199456 Sodium channel blockers
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354601A1 Transplantation rejection inhibitors
10/22/2003EP1354594A1 Combinations of an extract of a vaccinium type plant and a carotene
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353903A2 Thiol-based naaladase inhibitors
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353669A1 Method for treating glaucoma ib
10/22/2003EP1144386B1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/22/2003EP1131073B1 Use of staurosporine derivatives for treating ocular neovascular diseases
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1451008A Pyranoindoles for treating alaucoma
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450995A 5-hydroxy indazole derivatives for treating glaucoma
10/22/2003CN1450994A 6-Hydroxy-indazole derivatives for treating glaucoma
10/22/2003CN1450908A Neurotoxic oligomers
10/22/2003CN1450897A 5HT2 agonists for controlling IOP and treating glaucoma
10/22/2003CN1450896A Use of indole derivatives for intracular pressure for reducing
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450059A Medicinal compound with anti-infection, anti-inflammatory and antipyretic, and improving immunity function
10/22/2003CN1449825A Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
10/22/2003CN1449821A Stable recombination human alpha interferon liquid preparation and productive process thereof
10/22/2003CN1449786A Medicine for treating eye disease
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125049C New crystal modification N of torasemide
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635616 Laminin 15
10/21/2003US6635251 Eotaxin-specific antibodies
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2114239C Pharmaceutical composition containing carbachol and other cholinergic substances
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085072A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 531